Literature DB >> 7523161

Immunotherapy with autologous bone-marrow transplantation: rationale and results.

S Bilgrami1, M Silva, A Cardoso, K B Miller, J L Ascensao.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7523161

Source DB:  PubMed          Journal:  Exp Hematol        ISSN： 0301-472X            Impact factor:   3.084


× No keyword cloud information.
  2 in total

1.  Low doses of rIL2 after autologous bone marrow transplantation induce a "prolonged" immunostimulation of NK compartment in high-grade non-Hodgkin's lymphomas.

Authors:  D Raspadori; F Lauria; M A Ventura; P L Tazzari; S Ferrini; M C Miggiano; D Rondelli; S Tura
Journal:  Ann Hematol       Date:  1995-10       Impact factor: 3.673

2.  Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma.

Authors:  A Pession; A Prete; F Locatelli; S Pierinelli; A L Pession; R Maccario; E Magrini; B De Bernardi; P Paolucci; G Paolucci
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.